Side-by-side comparison of AI visibility scores, market position, and capabilities
Frankfurt-listed (ETR: P911) luxury sports car maker at €40.5B revenue with 911, Taycan, and Cayenne; IPO at €75B valuation competing with Ferrari and Lamborghini for performance automotive premium positioning.
Porsche AG is a Stuttgart, Germany-based luxury sports car and SUV manufacturer — listed on Frankfurt Stock Exchange (ETR: P911) and majority-controlled by Volkswagen Group — producing the 911, Cayenne, Macan, Panamera, Taycan, and 718 Boxster/Cayman models that collectively generate €40.5 billion in revenue in fiscal year 2024 with an 11.1% return on sales margin. Founded by Ferdinand Porsche in 1931 and made publicly listed in September 2022 (one of Europe's largest IPOs at a €75 billion valuation), Porsche is one of the world's most profitable automakers by margin — the premium pricing and controlled production of Porsche vehicles commands industry-leading profitability.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.